OTC · Drug Manufacturers - Specialty & Generic

Neptune Wellness Solutions Inc. (NEPTF) Stock

$0.00 OTC: NEPTF Healthcare

Neptune Wellness Solutions Inc. operates as a consumer packaged goods enterprise, conducting business across Canada, the United States, and internationally.

Valuation

MetricValue
Price$0.00
Market Cap$453
P/E Ratio-2.74
P/B Ratio4.85
P/S Ratio0.00
EPS (TTM)$-8064.11
52-Week High$0.03
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE500.00%
ROA-66.98%
ROCE-98.38%
Gross Margin-1.94%
Operating Margin-232.88%
Net Margin-136.83%
Debt/Equity-2.08
Current Ratio0.23

Annual Financials (USD)

Metric20192020202120222023
Revenue$18.0M$21.0M$35.0M$61.0M$53.0M
Operating Profit$-17.0M$-109.0M$-131.0M$-111.0M$-103.0M
Net Profit$-24.0M$-61.0M$-123.0M$-94.0M$-60.0M
EPS$-10.41$-25.15$-49744.24$-31066.90$-8192.00
Op Margin-93.3%-523.8%-369.7%-181.4%-195.5%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$90.0M$119.0M$187.0M$131.0M$31.0M
Total Liabilities$21.0M$18.0M$48.0M$55.0M$58.0M
Cash$10.0M$12.0M$60.0M$11.0M$2.0M
Borrowings$3.0M$3.0M$18.0M$18.0M$25.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-8.0M$-24.0M$-56.0M$-68.0M$-29.0M
Investing Cash Flow$-16.0M$-29.0M$-17.0M$-6.0M$1.0M
Financing Cash Flow$0$-4.0M$-1.0M$-2.0M$-1.0M
Net Cash Flow$-18.0M$5.0M$48.0M$-64.0M$-7.0M
Free Cash Flow$-18.0M$-35.0M$-63.0M$-71.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.07
FCF Yield-6401766.00%
Quick Ratio0.67
Interest Coverage-47.68
Return 1Y-99.29%
Return 3Y-100.00%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Federation Des Caisses Desjardins Du Quebec432024-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACUSAcusphere, Inc. $0.00 — 0.00 $49 0.00%
AQSZFAequus Pharmaceuticals Inc. $0.00 — -1.52 $159161 0.00%
DVLPGolden Developing Solutions, Inc. $0.00 — 0.00 $1413 0.00%
EVARFLombard Medical, Inc. $0.00 — 0.00 $2795 0.00%
IVIXFInvion Limited $0.04 +0.00% -0.31 $4.03M 0.00%

About Neptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc. operates as a consumer packaged goods enterprise, conducting business across Canada, the United States, and internationally. Its extensive product range features omega-3 fish oils and other dietary supplements, in addition to specialized softgel solutions offered under the Biodroga brand. The company also provides MaxSimil, an advanced omega-3 fatty acid delivery system that utilizes enzymes to pre-digest these fatty acids for improved absorption. Targeting the plant-based market, Neptune supplies vegan multi-omega gummies and soft gels via its Forest Remedies brand, and offers organic baby food products under its Sprout labels. These offerings reach consumers through a variety of distribution channels, including wholesale distributors, physical retail stores, grocery chains, and online platforms such as forestremedies.com, sproutorganics.com, and other e-commerce sites. Incorporated in 1998, Neptune Wellness Solutions Inc. is based in Laval, Canada.

Neptune Wellness Solutions Inc. (NEPTF) stock trades at $0.00 with a market capitalization of $453. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.74, reflecting a net loss over the last twelve months, price-to-book of 4.85, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 100.0% below its 52-week high.

On profitability, Neptune Wellness Solutions Inc. generates a return on equity (ROE) of 500.00% (not meaningful, as shareholders' equity is negative), return on capital employed of -98.38%, an operating margin of -232.88%, a net profit margin of -136.83%.

Official website: www.neptunewellness.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.